Data as of 4:01pm ET
| -0.18 / -2.30%|
The 3 analysts offering 12-month price forecasts for TherapeuticsMD Inc have a median target of 9.00, with a high estimate of 10.00 and a low estimate of 8.00. The median estimate represents a +17.80% increase from the last price of 7.64.
The current consensus among 3 polled investment analysts is to Buy stock in TherapeuticsMD Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.